Free Trial

Investors Purchase Large Volume of Call Options on Schrödinger (NASDAQ:SDGR)

Schrödinger logo with Medical background

Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors purchased 2,436 call options on the stock. This is an increase of approximately 257% compared to the average daily volume of 683 call options.

Hedge Funds Weigh In On Schrödinger

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. KBC Group NV increased its holdings in shares of Schrödinger by 45.4% during the third quarter. KBC Group NV now owns 2,508 shares of the company's stock valued at $47,000 after acquiring an additional 783 shares in the last quarter. Quarry LP increased its stake in Schrödinger by 1,150.0% during the 3rd quarter. Quarry LP now owns 2,825 shares of the company's stock valued at $52,000 after purchasing an additional 2,599 shares in the last quarter. GAMMA Investing LLC raised its holdings in Schrödinger by 87.5% in the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock worth $54,000 after buying an additional 1,305 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Schrödinger in the third quarter worth approximately $102,000. Finally, Point72 DIFC Ltd purchased a new stake in shares of Schrödinger during the third quarter valued at approximately $151,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Schrödinger Stock Performance

SDGR stock traded up $0.07 on Thursday, reaching $24.41. The company's stock had a trading volume of 1,914,837 shares, compared to its average volume of 908,299. The business has a fifty day simple moving average of $20.59 and a two-hundred day simple moving average of $20.06. The firm has a market cap of $1.78 billion, a PE ratio of -10.43 and a beta of 1.59. Schrödinger has a 12-month low of $16.67 and a 12-month high of $33.63.

Schrödinger (NASDAQ:SDGR - Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share for the quarter, missing analysts' consensus estimates of ($0.40) by ($0.12). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company had revenue of $35.30 million for the quarter, compared to the consensus estimate of $41.25 million. During the same period in the previous year, the firm posted ($0.86) EPS. The company's revenue for the quarter was down 17.1% on a year-over-year basis. As a group, research analysts anticipate that Schrödinger will post -2.29 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, BMO Capital Markets raised their price objective on Schrödinger from $25.00 to $28.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $32.90.

Read Our Latest Report on Schrödinger

Schrödinger Company Profile

(Get Free Report)

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

See Also

Should You Invest $1,000 in Schrödinger Right Now?

Before you consider Schrödinger, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.

While Schrödinger currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines